Treatment options for proliferative lupus nephritis: an update of clin- ical trial evidence. Drugs 2008; 68: 2095-104.Navaneethan SD, Viswanathan G, Strippoli GF. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Drugs 2008;68:2095-104....
The revised International Society of Nephrology/Renal Pathology Society 2003 classification defines the subclasses of lupus nephritis (LN) according to their pathological glomerular patterns, which has a crucial impact on the prognosis and treatment options for LN patients. There are widely accepted ...
The current era has witnessed the emergence of multiple novel therapeutic options, such as calcineurin inhibitors and biologic agents that target key pathogenetic mechanisms of lupus nephritis. Clinical outcomes have improved in parallel with these therapeutic advances. This Review discusses the evidence ...
During recent years, no major progress has been made regarding new treatment options except for the introduction of mycophenolate mofetil. Therefore, the results of several large clinical trials using biological agents for treatment of SLE were hopefully awaited. Yet, the application of abatacept, ...
OBJECTIVE: To provide an up-to-date review of the etiology, epidemiology, clinical features, diagnostic findings, and treatment options for systemic lupus erythematosus (SLE). DATA SOURCES: A PubMed search of English language articles using a combination of words: elderly, systemic lupus erythematosu...
The prognosis of systemic lupus erythematosus has improved markedly. This has been due to various factors: improved serological testing leading to better d
Introduction: Renal involvement affects over half of the patients with systemic lupus erythematosus. Lupus nephritis (LN) is an important cause of morbidity, mortality and renal failure. Treatment of LN has evolved over the past few decades with the advent of new therapeutic options, and the clini...
Mycophenolate mofetil for lupus nephritis Approved treatment options for moderate-to-severe systemic lupus erythematosus (SLE) and lupus nephritis (LN) are presently very limited. Mycophenolate mof... Ewa,Olech,Joan,... - 《Expert Review of Clinical Immunology》 被引量: 35发表: 2008年 Comparative...
When you get Lupus, your immune system attacks your tissues, leading to various illnesses. Learn more about symptoms, complications, causes, types, diagnosis, & treatment options.
Therapies which target this acute inflammatory response therefore represent biologically plausible treatment options for acute CPP crystal arthritis. Colchicine Colchicine is an ancient drug that has established efficacy in the treatment of diseases characterised by auto-inflammation [8]. These include gout,...